We all can agree that the significant delays with the CE Mark have been very very frustrating and concerning. Clearly this process has taken a toll on many investors, not to mention potential new patients. We can all debate why it has taken so long. Either way the market appears to be disinterested. A consequence of taking too much time for the approval after repeatedly being told that this would occur in 2017, 2018 and here we are now in 2019.
OSL Price at posting:
17.5¢ Sentiment: Hold Disclosure: Held
